Skip to main content

Table 4 (Abstract O22). Microparticles (MPs) levels in AAV patients with active or inactive disease and healthy controls

From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one

 

Active AAV

Inactive AAV

Healthy controls

p-value (respectively)

median

IQR

median

IQR

median

IQR

Tissue factor

265

247

174

107

105

84,5

p < 0.01* p < 0.001**

NETs

112

24

103

18

44

35

p < 0.05* p < 0.0001** p < 0.001***

Pentraxin3

1332

1810

347

294,5

184

146,5

p < 0.01* p < 0.0001** ns***

HMGB1

684

452,5

380

258

77

61,5

p < 0.01* p < 0.001** p < 0.001***

TWEAK

131

83

141

102,5

67

53

ns* p < 0.0001** p < 0.05***

Plasminogen

86

23

89

23

44

33,5

ns* p < 0.001** p < 0.01***

C3a

201

91

147

87

89

72

ns* p < 0.001** p < 0.05***

C5a

131

86,5

111

65

51

30

ns* p < 0.001** p < 0.01***

  1. *between active and inactive, ** between active and controls, ***between inactive and controls